News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
480,493 Results
Type
Article (38017)
Company Profile (165)
Press Release (442311)
Multimedia
Podcasts (58)
Webinars (11)
Section
Business (128826)
Career Advice (1098)
Deals (21726)
Drug Delivery (107)
Drug Development (46221)
Employer Resources (162)
FDA (11603)
Job Trends (11620)
News (214242)
Policy (22892)
Tag
Academia (2546)
Academic (2)
Accelerated approval (3)
Adcomms (19)
Allergies (60)
Alliances (35547)
ALS (60)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (100)
Approvals (11634)
Artificial intelligence (258)
Autoimmune disease (17)
Automation (14)
Bankruptcy (178)
Best Places to Work (9887)
BIOSECURE Act (15)
Biosimilars (98)
Biotechnology (98)
Bladder cancer (59)
Brain cancer (16)
Breast cancer (198)
Cancer (1472)
Cardiovascular disease (146)
Career advice (975)
Career pathing (31)
CAR-T (88)
Cell therapy (274)
Cervical cancer (18)
Clinical research (37390)
Collaboration (672)
Compensation (151)
Complete response letters (11)
COVID-19 (2397)
CRISPR (34)
C-suite (210)
Cystic fibrosis (69)
Data (1620)
Decentralized trials (2)
Denatured (28)
Depression (39)
Diabetes (208)
Diagnostics (5513)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (91)
Drug pricing (105)
Drug shortages (13)
Duchenne muscular dystrophy (71)
Earnings (41279)
Editorial (33)
Employer branding (23)
Employer resources (137)
Events (84844)
Executive appointments (642)
FDA (12646)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (658)
Gene editing (73)
Generative AI (24)
Gene therapy (211)
GLP-1 (565)
Government (4369)
Grass and pollen (4)
Guidances (123)
Healthcare (16140)
Huntington's disease (18)
IgA nephropathy (22)
Immunology and inflammation (69)
Indications (21)
Infectious disease (2539)
Inflammatory bowel disease (115)
Inflation Reduction Act (10)
Influenza (52)
Intellectual property (60)
Interviews (152)
IPO (9212)
IRA (37)
Job creations (2135)
Job search strategy (862)
Kidney cancer (4)
Labor market (40)
Layoffs (278)
Leadership (13)
Legal (4464)
Liver cancer (51)
Lung cancer (215)
Lymphoma (98)
Machine learning (7)
Management (52)
Manufacturing (231)
MASH (54)
Medical device (10171)
Medtech (10175)
Mergers & acquisitions (12941)
Metabolic disorders (550)
Multiple sclerosis (65)
NASH (16)
Neurodegenerative disease (62)
Neuropsychiatric disorders (17)
Neuroscience (1495)
NextGen: Class of 2025 (5693)
Non-profit (4306)
Now hiring (39)
Obesity (298)
Opinion (162)
Ovarian cancer (48)
Pain (62)
Pancreatic cancer (40)
Parkinson's disease (103)
Partnered (19)
Patents (142)
Patient recruitment (79)
Peanut (33)
People (43579)
Pharmaceutical (44)
Pharmacy benefit managers (18)
Phase I (11883)
Phase II (15107)
Phase III (13177)
Pipeline (956)
Policy (136)
Postmarket research (1748)
Preclinical (4565)
Press Release (64)
Prostate cancer (79)
Psychedelics (26)
Radiopharmaceuticals (173)
Rare diseases (285)
Real estate (4165)
Recruiting (61)
Regulatory (15684)
Reports (48)
Research institute (2200)
Resumes & cover letters (132)
Rett syndrome (3)
RNA editing (5)
RSV (41)
Schizophrenia (59)
Series A (112)
Series B (77)
Service/supplier (10)
Sickle cell disease (51)
Special edition (15)
Spinal muscular atrophy (107)
Sponsored (25)
Startups (2858)
State (1)
Stomach cancer (8)
Supply chain (54)
Tariffs (30)
The Weekly (29)
Vaccines (632)
Venture capitalists (39)
Weight loss (183)
Women's health (34)
Worklife (16)
Date
Today (66)
Last 7 days (657)
Last 30 days (2128)
Last 365 days (23771)
2025 (8685)
2024 (25767)
2023 (29055)
2022 (38692)
2021 (42450)
2020 (42190)
2019 (37823)
2018 (28261)
2017 (21842)
2016 (22863)
2015 (25917)
2014 (19689)
2013 (16218)
2012 (17375)
2011 (17799)
2010 (16153)
Location
Africa (658)
Alabama (34)
Alaska (6)
Arizona (153)
Arkansas (12)
Asia (26565)
Australia (4736)
California (4233)
Canada (1525)
China (370)
Colorado (209)
Connecticut (222)
Delaware (121)
Europe (61160)
Florida (675)
Georgia (177)
Hawaii (1)
Idaho (42)
Illinois (434)
India (27)
Indiana (299)
Iowa (9)
Japan (133)
Kansas (84)
Kentucky (22)
Louisiana (11)
Maine (68)
Maryland (698)
Massachusetts (3299)
Michigan (186)
Minnesota (278)
Mississippi (2)
Missouri (84)
Montana (17)
Nebraska (21)
Nevada (56)
New Hampshire (53)
New Jersey (1403)
New Mexico (22)
New York (1381)
North Carolina (775)
North Dakota (9)
Northern California (1926)
Ohio (156)
Oklahoma (12)
Oregon (28)
Pennsylvania (1039)
Puerto Rico (10)
Rhode Island (24)
South America (871)
South Carolina (19)
South Dakota (1)
Southern California (1526)
Tennessee (98)
Texas (580)
United States (17276)
Utah (173)
Virginia (98)
Washington D.C. (54)
Washington State (426)
West Virginia (3)
Wisconsin (57)
480,493 Results for "linear health sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Linear Health Sciences Reports Clinical, Commercial Milestones
Medical device company Linear Health Sciences today announced multiple clinical and commercial milestones for its Orchid SRV™ , a breakaway safety valve designed to improve the use of medical tubing in hospitals.
June 26, 2024
·
3 min read
BioMidwest
Linear Health Sciences Publishes Whitepaper Examining IV Dislodgement
Linear Health Sciences announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.
March 27, 2024
·
3 min read
Business
Linear Health Sciences Awarded IV Therapy Products - Needleless Connectors Agreement with Premier, Inc.
Linear Health Sciences has been awarded a national group purchasing agreement for the IV Therapy - Needleless Connectors category with Premier, Inc. Effective Jan. 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Orchid SRV force-activated separation device.
January 10, 2024
·
2 min read
BioMidwest
Linear Health Sciences Announces Expanded Indication for Orchid Safety Release Valve
Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™ safety release valve.
October 17, 2023
·
4 min read
Business
Linear Health Sciences Advances Orchid SRV Commercialization With Two Key Hires
Medical device company Linear Health Sciences today advanced the commercialization of its Orchid SRV ™ tension-activated breakaway safety release valve, announcing the appointment of Rob Headley as vice president of sales and business development, and Jessica Czamanski as director of product and regulatory affairs.
June 27, 2023
·
3 min read
Policy
Linear Health Sciences Announces Expanded Pediatric Indication for Orchid Safety Release Valve
Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.
May 16, 2023
·
3 min read
Press Releases
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
March 19, 2025
·
4 min read
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Business
Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device
Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.
November 8, 2022
·
4 min read
1 of 48,050
Next